Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Get Free Report) traded down 1.4% on Wednesday . The company traded as low as $0.4950 and last traded at $0.4950. 719,226 shares changed hands during trading, an increase of 3,079% from the average session volume of 22,626 shares. The stock had previously closed at $0.5020.
Bellevue Life Sciences Acquisition Trading Down 5.0%
The business has a 50-day simple moving average of $0.54 and a two-hundred day simple moving average of $0.57.
About Bellevue Life Sciences Acquisition
Bellevue Life Sciences Acquisition Corp. (NASDAQ: BLAC) is a special purpose acquisition company organized as a Delaware corporation. The company completed its initial public offering in 2021, raising gross proceeds to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more life sciences businesses.
BLAC’s principal activity is to identify and complete a business combination with a target operating company in the life sciences sector.
Further Reading
- Five stocks we like better than Bellevue Life Sciences Acquisition
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
